Unknown

Dataset Information

0

Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.


ABSTRACT: The serotonin 2A receptor (5-HT2AR) is implicated in the pathophysiology and treatment of various psychiatric disorders. [18 F]altanserin and [11 C]Cimbi-36 positron emission tomography (PET) allow for high-resolution imaging of 5-HT2AR in the living human brain. Cerebral 5-HT2AR binding is strongly genetically determined, though the impact of specific variants is poorly understood. Candidate gene studies suggest that HTR2A single nucleotide polymorphisms including rs6311/rs6313, rs6314, and rs7997012 may influence risk for psychiatric disorders and mediate treatment response. Although known to impact in vitro expression of 5-HT2AR or other serotonin (5-HT) proteins, their effect on human in vivo brain 5-HT2AR binding has as of yet been insufficiently studied. We thus assessed the extent to which these variants and the commonly studied 5-HTTLPR predict neocortex in vivo 5-HT2AR binding in healthy adult humans. We used linear regression analyses and likelihood ratio tests in 197 subjects scanned with [18 F]altanserin or [11 C]Cimbi-36 PET. Although we observed genotype group differences in 5-HT2AR binding of up to ~10%, no genetic variants were statistically significantly predictive of 5-HT2AR binding in what is the largest human in vivo 5-HT2AR imaging genetics study to date. Thus, in vitro and post mortem results suggesting effects on 5-HT2AR expression did not carry over to the in vivo setting. To any extent these variants might affect clinical risk, our findings do not support that 5-HT2AR binding mediates such effects. Our observations indicate that these individual variants do not significantly contribute to genetic load on human in vivo 5-HT2AR binding.

SUBMITTER: Spies M 

PROVIDER: S-EPMC7555071 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.

Spies Marie M   Nasser Arafat A   Ozenne Brice B   Jensen Peter S PS   Knudsen Gitte M GM   Fisher Patrick M PM  

Human brain mapping 20200722 16


The serotonin 2A receptor (5-HT2AR) is implicated in the pathophysiology and treatment of various psychiatric disorders. [<sup>18</sup> F]altanserin and [<sup>11</sup> C]Cimbi-36 positron emission tomography (PET) allow for high-resolution imaging of 5-HT2AR in the living human brain. Cerebral 5-HT2AR binding is strongly genetically determined, though the impact of specific variants is poorly understood. Candidate gene studies suggest that HTR2A single nucleotide polymorphisms including rs6311/r  ...[more]

Similar Datasets

| S-EPMC3237193 | biostudies-literature
| S-EPMC4702415 | biostudies-literature
| S-EPMC8745376 | biostudies-literature
| S-EPMC5720374 | biostudies-literature
| S-EPMC4319849 | biostudies-literature
| S-EPMC3044825 | biostudies-literature
| S-EPMC5295009 | biostudies-literature
| S-EPMC4134733 | biostudies-literature
| S-EPMC6943889 | biostudies-literature
| S-EPMC6869129 | biostudies-literature